MIRA INFORM REPORT

 

 

Report Date :

22.12.2007

 

IDENTIFICATION DETAILS

 

Name :

NEXO PHARMACEUTICAL GROUP S.A.

 

 

Registered Office :

Billinghurst 1506 6º F, Buenos Aires City

 

 

Country :

Argentina

 

 

Date of Incorporation :

05/09/2000

 

 

Legal Form :

Public Limited Company

 

 

Line of Business :

Chemical Industry, Laboratory Products, Chemical Substances, Botanical Products, Pharmaceutical and Veterinary Products, Cosmetics, Perfumes, Hygiene Items and Toiletries

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 


Registered Name   

 

NEXO PHARMACEUTICAL GROUP S.A.

CUIT Nº 30-70735437-9

 

 

Summary      

 

INCORPORATED IN SEPTEMBER OF 2000. BEGINNER OF ACTIVITIES. CORPORATE STOCK: $ 72.000. IT REFUSES TO SUPPLY ANY TYPE OF FINANCIAL INFORMATION. UP TO NOW, IT DOES NOT REGISTER NEGATIVE ELEMENTS AND HAS STABLE PERSPECTIVES. FULLFILMENT: WITHOUT OBJECTIONS. FIT FOR MODERATED CREDITS. FOR HIGHER AMOUNTS TAKE APPROPRIATE GUARANTEES.

 

 

Operations       

 

CHEMICAL INDUSTRY, LABORATORY PRODUCTS, CHEMICAL SUBSTANCES, BOTANICAL PRODUCTS, PHARMACEUTICAL AND VETERINARY PRODUCTS, COSMETICS, PERFUMES, HYGIENE ITEMS AND TOILETRIES

 

 

Legal Structure   

 

BUSINESS TYPE:           PUBLIC LIMITED COMPANY
INCORPORATED:           05/09/2000
REGISTERED:                2000
DURATION:                     99 YEARS
END OF FISCAL YEAR:  DECEMBER 31st

 

 

Contact       

 

Legal address: Billinghurst 1506 6º F, Buenos Aires City.

Operative address: Don Orione 1185, Victoria, Buenos Aires Province.
Phone: (54-11)4746.4306

Other Dependences: Ponferrada 285, Moron, Buenos Aires Province.

 

 

 

Partners     

 

PRESIDENT:        ERNESTO SZINI
DIRECTOR:         FERNANDA ELIZABETH RODRIGUEZ

Signature Use: In charge of the President.

 

 

Corporate Stock       

 

COMMON SHARES
SUBSCRIBED AND PAID-IN CAPITAL $ 72.000

 

 

Personal Information   

 

ERNESTO SZINI
Argentinian, DNI. 16.672.825, married, born on 18/2/1964, with address in 33 0rientales 335, San Isidro (Buenos Aires).

FERNANDA ELIZABETH RODRIGUEZ
Argentinian, DNI. 18.195.307, married, born on 4/7/1966, with the same address that the above mentioned one.

They are both registered in the following companies: MACROPIXEL S.A., URGONYA S.R.L. and NORTH START S.A..

 

 

History   

 

The mentioned activities were started by this company on 05/09/2000.

 

 

Economic-Financial Position   

 

Contact has been taken with the accountant Victor Rojas (Administrative Manager), who refused to supply information.

Other consulted sources indicate that this company operates with a medium level of economic importance and that its performance does not register setbacks.

 

 

 

Assets     

 

The company owns the property located in Don Orione 1185, Victoria, Buenos Aires Province, which has an important realization value.

 

 

Evolution and Results       

 

This company performs the mentioned activities. It has an appropriate operative structure, where it employs 20 people supervised by the main representatives.

Up to now, it has a normal performance and stable perspectives.

During the last 12 months it has carried out imports for the amount of U$S 17.656 from China and India. The imported products were heterocyclic compounds and preparations for therapeutic use.

Up to now, it does not register ups and downs.

MAIN SUPPLIERS:
--------------
LABSA S.R.L..
ARCANO S.A.
ROMIQUIN S.A.
POLITRUCQ (INDIA)

 

 

Payment Record and Credit Risk      

 

BANKS:
-----
BANCO SANTANDER RIO
BANCO CREDICOOP LTDO
BANCO PATAGONIA SUDAMERIS

INSURANCE:
---------
MAPFRE CIA. DE SEGUROS S.A.
General Risks.

 

 

Concept       

 

Up to now, the subject company has a good payment record and a good concept among its sector.

IT IS A WELL QUALIFIED COMPANY.

 

Final Opinion    

 

 

We can finally consider feasible the credit treatment with this company by moderated amounts.

For higher amounts, we suggest taking appropriate guarantees.

FIT FOR CREDIT TREATMENT.

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions